0001628280-23-041166.txt : 20231208 0001628280-23-041166.hdr.sgml : 20231208 20231208175815 ACCESSION NUMBER: 0001628280-23-041166 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231206 FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waters Kevin CENTRAL INDEX KEY: 0001653771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40797 FILM NUMBER: 231476549 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp CENTRAL INDEX KEY: 0001588978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 260199180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 ISLAND DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-232-7200 MAIL ADDRESS: STREET 1: 900 ISLAND DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94065 4 1 wk-form4_1702076286.xml FORM 4 X0508 4 2023-12-06 0 0001588978 PROCEPT BioRobotics Corp PRCT 0001653771 Waters Kevin C/O PROCEPT BIOROBOTICS CORPORATION 150 BAYTECH DRIVE SAN JOSE CA 95134 0 1 0 0 EVP, CFO 1 Common Stock 2023-12-06 4 M 0 4360 4.52 A 37883 D Common Stock 2023-12-07 4 M 0 3837 4.52 A 41720 D Common Stock 2023-12-08 4 M 0 6888 4.52 A 48608 D Common Stock 2023-12-06 4 S 0 4360 40.0214 D 44248 D Common Stock 2023-12-07 4 S 0 3837 40 D 40411 D Common Stock 2023-12-08 4 S 0 6888 40.0174 D 33523 D Stock Option (Right to Buy) 4.52 2023-12-06 4 M 0 4360 0 D 2028-10-22 Common Stock 4360 203357 D Stock Option (Right to Buy) 4.52 2023-12-07 4 M 0 3837 0 D 2028-10-22 Common Stock 3837 199520 D Stock Option (Right to Buy) 4.52 2023-12-08 4 M 0 6888 0 D 2028-10-22 Common Stock 6888 192632 D All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0000 to $40.1500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0000 to $40.0350, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The Stock Option was granted on October 23, 2018 and vested over a four year period. /s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters 2023-12-08